| Literature DB >> 24794112 |
Cody J Wenthur1, Ryan D Morrison1, J Scott Daniels1, P Jeffrey Conn1, Craig W Lindsley2.
Abstract
Herein we report the design and synthesis of a series of substituted pyrazolo[1,5-a]quinazolin-5(4H)-ones as negative allosteric modulators of metabotropic glutamate receptors 2 and 3 (mGlu2 and mGlu3, respectively). Development of this series was initiated by reports that pyrazolo[1,5-a]quinazoline-derived scaffolds can yield compounds with activity at group II mGlu receptors which are prone to molecular switching following small structural changes. Several potent analogues, including 4-methyl-2-phenyl-8-(pyrimidin-5-yl)pyrazolo[1,5-a]quinazolin-5(4H)-one (10b), were discovered with potent in vitro activity as dual mGlu2/mGlu3 NAMs, with excellent selectivity versus the other mGluRs.Entities:
Keywords: Metabotropic glutamate receptor 2; Metabotropic glutamate receptor 3; Negative allosteric modulator (NAM); mGlu(2) receptor; mGlu(3) receptor
Mesh:
Substances:
Year: 2014 PMID: 24794112 PMCID: PMC4075068 DOI: 10.1016/j.bmcl.2014.04.051
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823